Patients with myasthenia gravis who are given edrophonium,an antagonist of cholinesterase,show:
A) Aggravation of symptoms
B) Complete paralysis
C) Temporary improvement of muscle weakness
D) Reduced levels of circulating antibodies
E) Reduced calcium in blood

Question

Quizplus · Accepted Answer

Edrophonium is a short-acting cholinesterase inhibitor that increases the availability of acetylcholine at the neuromuscular junction, improving muscle strength temporarily. Therefore, patients with myasthenia gravis who are given edrophonium will experience a temporary improvement of muscle weakness.

Patients with Myasthenia Gravis Who Are Given Edrophonium,an Antagonist of Cholinesterase,show